- Home
- ELME vs KNSA Comparison
ELME vs KNSA Comparison
Compare ELME & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELME
- KNSA
- Stock Information
- Founded
- ELME 1960
- KNSA 2015
- Country
- ELME United States
- KNSA United Kingdom
- Employees
- ELME N/A
- KNSA N/A
- Industry
- ELME Real Estate Investment Trusts
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- ELME Real Estate
- KNSA Health Care
- Exchange
- ELME Nasdaq
- KNSA Nasdaq
- Market Cap
- ELME 1.5B
- KNSA 1.7B
- IPO Year
- ELME N/A
- KNSA 2018
- Fundamental
- Price
- ELME $16.16
- KNSA $21.28
- Analyst Decision
- ELME Hold
- KNSA Strong Buy
- Analyst Count
- ELME 5
- KNSA 5
- Target Price
- ELME $17.50
- KNSA $36.60
- AVG Volume (30 Days)
- ELME 587.6K
- KNSA 365.0K
- Earning Date
- ELME 11-04-2024
- KNSA 10-29-2024
- Dividend Yield
- ELME 4.46%
- KNSA N/A
- EPS Growth
- ELME N/A
- KNSA N/A
- EPS
- ELME N/A
- KNSA N/A
- Revenue
- ELME $239,523,000.00
- KNSA $384,098,000.00
- Revenue This Year
- ELME N/A
- KNSA $60.05
- Revenue Next Year
- ELME $2.78
- KNSA $36.32
- P/E Ratio
- ELME N/A
- KNSA N/A
- Revenue Growth
- ELME 6.62
- KNSA 54.41
- 52 Week Low
- ELME $12.74
- KNSA $15.52
- 52 Week High
- ELME $18.49
- KNSA $28.15
- Technical
- Relative Strength Index (RSI)
- ELME 40.28
- KNSA 36.27
- Support Level
- ELME $15.56
- KNSA $20.41
- Resistance Level
- ELME $17.89
- KNSA $21.55
- Average True Range (ATR)
- ELME 0.43
- KNSA 0.84
- MACD
- ELME -0.11
- KNSA -0.10
- Stochastic Oscillator
- ELME 25.75
- KNSA 28.02
About ELME Elme Communities
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located primarily near major transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's largest tenants are banking, consulting, law, and financial services firms.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.